LABD | Direxion Daily S&P Biotech Bear 3X ETFAMEXETF golden cross and death cross projections, cross tests and history

$7.08
-$0.43 (-5.73%)

Direxion Daily S&P Biotech Bear 3X ETF (LABD) is an AMEX-listed ETF that Cruxta has tracked for 50/200 crosses since 2018.

The 50 SMA has sat below the 200 on the daily since Jul 2025, with no cross projected inside the 30 bars Cruxta tracks. Price sits below the 50 and the 200 on the daily, the weekly and the 4-hour.

Timeframe summary

Daily as of 3 Nov 16:00 ET

Price
below both $7.08 vs 50 $7.28 / 200 $12.16
Projection
No cross projected
Test
No active test
Last cross
Death cross 28 Jul 2025 ยท projected 26 bars out

Weekly as of 30 Oct 16:00 ET

Price
below both $6.98 vs 50 $13.89 / 200 $81.41
Projection
No cross projected
Test
No active test
Last cross
No cross on record

4-hour as of 3 Nov 13:30 ET

Price
below both $6.96 vs 50 $7.67 / 200 $7.88
Projection
No cross projected
Test
No active test
Last cross
Death cross 13 Jun 2025 ยท projected 28 bars out

Cross history

20
crosses on record since 2018
10 golden10 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
28 Jul 2025Death steepdaily26 bars outNot tested
13 Jun 2025Death4-hour28 bars outโ€”
11 Feb 2025Goldendaily27 bars out3 bar cross test
13 Dec 2024Golden4-hour14 bars outโ€”
3 Jun 2024Death4-hour18 bars outโ€”

About LABD

ExchangeAMEX
InstrumentETF
Median $ volume, 60 d$146M
4-hour coverageYes, since Oct 2025
History on recordSince 2018

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.